2022
Differences in the Delivery of Medications for Opioid use Disorder during Hospitalization by Racial Categories: A Retrospective Cohort Analysis;
Priest K, King C, Englander H, Lovejoy T, McCarty D. Differences in the Delivery of Medications for Opioid use Disorder during Hospitalization by Racial Categories: A Retrospective Cohort Analysis;. Substance Abuse 2022, 43: 1251-1259. PMID: 35670778, PMCID: PMC10292919, DOI: 10.1080/08897077.2022.2074601.Peer-Reviewed Original ResearchConceptsOpioid use disorderVeterans Health AdministrationWhite patientsUse disordersMOUD deliveryBlack patientsDelivery of buprenorphineType of MOUDRetrospective cohort analysisAcute care hospitalsCOVID-19 pandemic continuesDelivery of medicationsOutpatient clinical environmentLogistic regression modelsMOUD accessAddiction treatment systemCare hospitalStudy cohortSurgical hospitalizationMean ageCohort analysisHospitalizationMOUDPatientsBuprenorphine
2021
Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality
King C, Cook R, Wheelock H, Korthuis P, Leahy J, Goff A, Morris C, Englander H. Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality. International Journal Of Drug Policy 2021, 100: 103525. PMID: 34837879, PMCID: PMC8810590, DOI: 10.1016/j.drugpo.2021.103525.Peer-Reviewed Original ResearchConceptsAddiction consult serviceOpioid use disorderDrug-related deathsConsult serviceHospital dischargeCare systemDrug-related causesOpioid-related deathsDrug supplyRisk of overdoseDrug-related mortalityOpioid overdose deathsHarm reduction interventionsAdult patientsOUD patientsHospital admissionOpioid overdosesEffective treatmentOverdose deathsSimulated cohortPatientsUse disordersReduction interventionsHospitalizationDeathUnderstanding the impact of the SARS-COV-2 pandemic on hospitalized patients with substance use disorder
King C, Vega T, Button D, Nicolaidis C, Gregg J, Englander H. Understanding the impact of the SARS-COV-2 pandemic on hospitalized patients with substance use disorder. PLOS ONE 2021, 16: e0247951. PMID: 33635926, PMCID: PMC7909702, DOI: 10.1371/journal.pone.0247951.Peer-Reviewed Original ResearchConceptsSubstance use disordersSARS-CoV-2 pandemicHospitalized patientsUse disordersHospital policy changesAcademic medical centerExperiences of healthcareAcute illnessOutpatient careMedical CenterPatientsHospitalCommunity resourcesDisordersPandemicQualitative studyThematic analysisSemi-structured interviewsSurvival adaptationHospitalizationIllnessMain themesCareTrust in Hospital Physicians Among Patients With Substance Use Disorder Referred to an Addiction Consult Service: A Mixed-methods Study
King C, Collins D, Patten A, Nicolaidis C, Englander H. Trust in Hospital Physicians Among Patients With Substance Use Disorder Referred to an Addiction Consult Service: A Mixed-methods Study. Journal Of Addiction Medicine 2021, 16: 41-48. PMID: 33577229, PMCID: PMC8349928, DOI: 10.1097/adm.0000000000000819.Peer-Reviewed Original ResearchConceptsAddiction consult serviceSubstance use disordersConsult serviceUse disordersAddiction medicine serviceGroup of patientsPatient-physician relationshipHospital dischargeHospitalized patientsPrior hospitalizationMedicine servicePatientsHospital physiciansHospitalized peopleHealthcare providersHospitalizationHospital trustsProvider trustMixed-methods studyMost participantsQualitative themesPhysiciansBaselineCareDisorders